Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Cellular therapy is an emerging therapeutic modality with a great potential for the treatment of autism. Recent findings show that the major underlying pathogenetic mechanisms of autism are hypoperfusion and immune alterations in the brain. So conceptually, cellular therapy which facilitates counteractive processes of improving perfusion by angiogenesis and balancing inflammation by immune regulation would exhibit beneficial clinical effects in patients with autism. This is an open label proof of concept study of autologous bone marrow mononuclear cells (BMMNCs) intrathecal transplantation in 32 patients with autism followed by multidisciplinary therapies. All patients were followed up for 26 months (mean 12.7). Outcome measures used were ISAA, CGI, and FIM/Wee-FIM scales. Positron Emission Tomography-Computed Tomography (PET-CT) scan recorded objective changes. Out of 32 patients, a total of 29 (91%) patients improved on total ISAA scores and 20 patients (62%) showed decreased severity on CGI-I. The difference between pre- and postscores was statistically significant (P<0.001) on Wilcoxon matched-pairs signed rank test. On CGI-II 96% of patients showed global improvement. The efficacy was measured on CGI-III efficacy index. Few adverse events including seizures in three patients were controlled with medications. The encouraging results of this leading clinical study provide future directions for application of cellular therapy in autism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“clinical trials using strategies to reconstitute immune cells in individuals with ASD have been initiated233,234.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [234]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Social perception from visual cues: Role of the STS region
Allison, T., Puce, A., & McCarthy, G. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01501-1 · Cited by 2,461 · cited 1×
“The areas of hypermetabolism implicated in previous imaging studies [59] showed reduction in metabolism after cellular transplantation, and areas having hypometabolism as suggested by Zilbovicius et al. 2000 [33] showed increased metabolism after cellular transplantation.”
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Identification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Adult outcome for children with autism
Howlin, P., Goode, S., Hutton, J., & Rutter, M. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00215.x · Cited by 1,813
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 2×
“Neuroanatomical studies suggest that frontal lobes, mesial temporal lobe (especially amygdala) and cerebellum are also involved in the pathology of autism [14].”
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332
The Epidemiology of Autism Spectrum Disorders
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., Mandell, D. S., Miller, L. A., Pinto-Martin, J., Reaven, J., et al. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144007 · Cited by 1,228
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
The Screening and Diagnosis of Autistic Spectrum Disorders
Filipek, P. A., Accardo, P. J., Baranek, G. T., Cook, E. H., Dawson, G., Gordon, B., Gravel, J. S., Johnson, C. P., Kallen, R. J., Levy, S. E., et al. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1021943802493 · Cited by 1,003 · cited 3×
“Presently, the worldwide incidence is 12 per 1000 children [1].”
Research works printed but not linked: 6
- 2012, Autism, 2, 2
- 2012, Indian Journal of Medical Research, 136, 221
- 2013, Journal of Translational Medicine, 26, 21
- 2010, Alternative Medicine Review, 15, 15
- 2006, Cell Molecular Neurobiology, 26, 1113
- 2002, Orvosi hetilap, 143, 1302
Cited by
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
“[318] was an open-label, proof-of-concept study with 32 patients and similar study plan; however, the patients were evaluated with Indian Scale for Assessment of Autism, Clinical Global Impression scale (CGI), and scales designed tomeasure independence in daily living.”
MethodDoes Rubella Cause Autism: A 2015 Reappraisal?
Hutton, J. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00025 · Cited by 100
“In theory, areas with decreased perfusion are linked to increased hypoxia and lower intelligence (Sharma et al., 2013; Zilbovicius et al., 2013).”
BackgroundZürcher, N. R., Bhanot, A., McDougle, C. J., & Hooker, J. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.002 · Cited by 108
Segal‐Gavish, H., Karvat, G., Barak, N., Barzilay, R., Ganz, J., Edry, L., Aharony, I., Offen, D., & Kimchi, T. (2016) · Autism Research · doi:10.1002/aur.1530 · Cited by 92
“In the context of ASD, several studies have provided encouraging data on the potential of fetal stem cells as well as umbilical cord-and bone mar- row-derived mononuclear cells, which include MSC, in children suffering from ASD (Bradstreet et al., 2014; Lv et al., 2013; Sharma et al., 2013).”
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M., Das, S. K., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 93
Nitkin, C. R., & Bonfield, T. L. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0427 · Cited by 79
Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018) · Neuroimmunomodulation · doi:10.1159/000492225 · Cited by 70
Bradstreet, J. J., Sych, N., Antonucci, N., Klunnik, M., Ivankova, O., Matyashchuk, I., Demchuk, M., & Siniscalco, D. (2014) · Cell Transplantation · doi:10.3727/096368914x684916 · Cited by 68
“Similarly, in a study conducted from the same research group, BMMNCs were able to improve autistic behaviors in 32 autistic patients (21).”
BackgroundResultSharma, A. K., Sane, H. M., Gokulchandran, N., Kulkarni, P., Gandhi, S., Sundaram, J., Paranjape, A., Shetty, A., Bhagwanani, K., Biju, H., et al. (2015) · Stem Cells International · doi:10.1155/2015/905874 · Cited by 63
Self-citationRah, W.-J., Lee, Y. H., Moon, J., Jun, H.-J., Kang, H.-R., Koh, H., Eom, H. J., Lee, J. Y., Lee, Y. J., Kim, J. Y., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1120-0 · Cited by 61
Riordan, N. H., Hincapié, M. L., Morales, I., Fernández, G., Allen, N., Leu, C., Madrigal, M., Paz Rodríguez, J., & Novarro, N. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0010 · Cited by 61
RetractedMancías‐Guerra, C., Marroquín-Escamilla, A. R., González‐Llano, Ó., Martinez, L. V., Jaime‐Pérez, J. C., Rodríguez, F. G., Valdés-Burnes, S. L., Rodríguez‐Romo, L., Barrera-Morales, D. C., Sánchez-Hernández, J. J., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.01.008 · Cited by 58
Stem cell therapy in autism: recent insights
Siniscalco, D., Kannan, S., Semprún-Hernández, N., Eshraghi, A. A., Brigida, A. L., & Antonucci, N. (2018) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s155410 · Cited by 63
“5 years, male:female 3:1) with confirmed diagnosis of autism.(88) The protocol included intrathecal cellular therapy followed by occupational therapy, sensory integrative approach, speech therapy, psychological intervention, and specific dietary recommendations.”
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Wang, Y., Meng, W., Liu, Z., An, Q., & Hu, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1046692 · Cited by 57
“Multiple clinical trials have reported favorable safety and efficacy of MSCs transplantation in children with ASD, including improvements in social relationships and reciprocity, emotional reactivity, speech, language, communication, behavioral patterns, sensory aspects, and cognition (Lv et al., 2013; Sharma et al.,…”
BackgroundPerets, N., Segal‐Gavish, H., Gothelf, Y., Barzilay, R., Barhum, Y., Abramov, N., Hertz, S., Morozov, D., London, M., & Offen, D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.047 · Cited by 55
Thanh, L. N., Nguyen, H.-P., Ngo, M., Bui, V. A., Dam, P. T. M., Bui, H. T. P., Ngo, D. V., Kiên, T. T., Dang, T. T. T., Duong, B. D., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0102 · Cited by 52
“Unable to integrate into school 16 (53) 15 (50) 11 (37) 8 (27)”
Autism spectrum disorder in India: a scoping review
Patra, S., & Kar, S. K. (2020) · International Review of Psychiatry · doi:10.1080/09540261.2020.1761136 · Cited by 56
Ha, S., Park, H., Mahmood, U., Ra, J. C., Suh, Y., & Chang, K.-A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.004 · Cited by 50
“9 mesenchymal stem cells (hUC-MSCs), human cord blood mononuclear cells (hCB-MNCs), autologous bone marrow stem cells or fetal stem cells [20-24].”
BackgroundEbrahimi, A., Ahmadi, H., Ghasrodashti, Z. P., Tanide, N., Shahriarirad, R., Erfani, A., Ranjbar, K., & Ashkani‐Esfahani, S. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.5508 · Cited by 56
Stem cell therapies in cerebral palsy and autism spectrum disorder
Sun, J. M., & Kurtzberg, J. (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14789 · Cited by 42
Cell therapy attempted as a novel approach for chronic traumatic brain injury – a pilot study
Sharma, A. K., Sane, H. M., Kulkarni, P., Yadav, J., Gokulchandran, N., Biju, H., & Badhe, P. B. (2015) · SpringerPlus · doi:10.1186/s40064-015-0794-0 · Cited by 42
“…strategy for various neurological disorders such as stroke, cerebral palsy, autism, spinal cord injury, and traumatic brain injury (Sharma et al. 2012a; Sharma et al. 2012b; Sharma et al. 2012c; Sharma et al. 2012d; Sharma et al. 2013a; Sharma et al. 2013b; Sharma et al. 2013c; Zhang et al. 2013).”
BackgroundSelf-citationMedical Therapies for Children With Autism Spectrum Disorder—An Update
Edwin Williamson, M. D., Sathe, N. A., & Andrews, J. C. (2017) · doi:10.23970/ahrqepccer189 · Cited by 47
Sharma, A. K., Sane, H. M., Paranjape, A., Gokulchandran, N., Nagrajan, A., D'sa, M., & Badhe, P. B. (2015) · Europe PMC (PubMed Central) · Cited by 36
Self-citationSharifzadeh, N., Ghasemi, A., Afshari, J. T., Moharari, F., Soltanifar, A., Talaeı, A., Pouryousof, H. R., Nahidi, M., Bordbar, M. R. F., & Ziaee, M. (2020) · Asia-Pacific Psychiatry · doi:10.1111/appy.12445 · Cited by 36
“Previous studies, despite reporting an improvement in symptoms of ASD after injection of stem cells in children with autism, were mainly focused on the safety of stem cell injection for ASD patients (Sharma et al., 2013).”
BackgroundResultSun, J. M., & Kurtzberg, J. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.03.004 · Cited by 37
“Autologous CB and/or bone marrow treatment in children with autism is currently under investigation in several countries [70,79].”
BackgroundHuang, H., Chen, L., Mao, G., & Sharma, H. S. (2020) · Journal of Neurorestoratology · doi:10.26599/jnr.2020.9040009 · Cited by 35
“A series of reports showed that autologous BMMNC therapy could improve quality of life in muscular dystrophy patients [102–105], and that it showed good benefit in autism [106], ALS [107], and brachial plexus injury [108].”
BackgroundCell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism
Sun, J. M., & Kurtzberg, J. (2017) · Pediatric Research · doi:10.1038/pr.2017.254 · Cited by 32
Martinez, L. V., González‐Martínez, G., Sáenz-Flores, M., Bautista-Gómez, A. J., González-Martínez, A., Ortiz-Castillo, M., Robles-Sáenz, D. A., & Garza-López, E. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10257-0 · Cited by 32
“Six studies were considered as fair [5, 9, 21, 23, 26, 29] and two studies as good [30, 31].”
BackgroundMethodInfluentialMicroglia as possible therapeutic targets for autism spectrum disorders
Andoh, M., Ikegaya, Y., & Koyama, R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.012 · Cited by 35
Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders
Liu, Q., Chen, M.-X., Sun, L., Wallis, C. U., Zhou, J., Ao, L., Li, Q., & Sham, P. C. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i2.55 · Cited by 32
Mesenchymal stem cells in treating autism: Novel insights
Siniscalco, D., Bradstreet, J. J., Sych, N., & Antonucci, N. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.173 · Cited by 29
Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism
Donegan, J. J., Boley, A. M., & Lodge, D. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0021-0 · Cited by 30
Rosemann, A., & Chaisinthop, N. (2015) · Social Studies of Science · doi:10.1177/0306312715619783 · Cited by 34
Criss‐crossing autism spectrum disorder and adult neurogenesis
Bicker, F., Nardi, L., Maier, J., Vasić, V., & Schmeißer, M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15501 · Cited by 28
Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
Tan, Z., Wei, H., Song, X., Mai, W., Yan, J., Ye, W., Ling, X., Hou, L., Zhang, S., Yan, S., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.806876 · Cited by 29
Sharma, A. K., Sane, H. M., Kulkarni, P., Gokulchandran, N., Biju, H., & Badhe, P. B. (2020) · Cell Regeneration · doi:10.1186/s13619-020-00043-7 · Cited by 29
“In past, few years, it has gained significant attention as a prospective therapeutic option for various neurological disorders (Sharma et al., 2012; Sharma et al., 2013a; 2013b; Zhang et al., 2013).”
BackgroundSelf-citationCurrent Proceedings of Cerebral Palsy
Fan, H.-C., Ho, L.-I., Chi, C.-S., Cheng, S.-N., Juan, C., Chiang, K.-L., Lin, S., & Harn, H.-J. (2015) · Cell Transplantation · doi:10.3727/096368915x686931 · Cited by 24
“Table 1 shows in the last 2 years, there are seven trials that were registered/launched in Korea, India, Mexico, US, and China.”
BackgroundInfluentialSharma, A. K., Gokulchandran, N., Kulkarni, P., Sane, H. M., Sharma, R., Jose, A., & Badhe, P. B. (2020) · Europe PMC (PubMed Central) · Cited by 31
Self-citationQu, J., Liu, Z., Li, L., Zou, Z., He, Z., Zhou, L., Luo, Y., Zhang, M., & Ye, J. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.897398 · Cited by 21
Wang, Y., Yu, S., & Li, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1226580 · Cited by 22
Translational Approaches to Autism Spectrum Disorder
Robinson‐Agramonte, M. D. L. Á. (2015) · Springer eBooks · doi:10.1007/978-3-319-16321-5 · Cited by 21
Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder—A Systematic Review
Paprocka, J., Kaminiów, K., Kozak, S., Sztuba, K., & Emich‐Widera, E. (2021) · Brain Sciences · doi:10.3390/brainsci11121606 · Cited by 22
Bone Marrow-Derived Mononuclear Cells in the Treatment of Neurological Diseases: Knowns and Unknowns
Nguyen, Q. T., Liêm, N. T., Hoang, V. T., Phan, T. T. K., Heke, M., & Hoang, D. M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01377-x · Cited by 21
Liêm, N. T., Vũ, D. C., Phuong, D. T. M., Doan, N. V., Forsyth, N. R., Heke, M., Thi, P. A. N., & Nguyen, X. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00564 · Cited by 20
Cell therapy approaches to autism: a review of clinical trial data
Price, J. (2020) · Molecular Autism · doi:10.1186/s13229-020-00348-z · Cited by 19
Peterson, C. W., Adair, J. E., Wohlfahrt, M. E., Deléage, C., Radtke, S., Rust, B. J., Norman, K. K., Norgaard, Z. K., Schefter, L. E., Sghia-Hughes, G., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.016 · Cited by 15
Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions
Larijani, B. A., Heravani, N. F., Alavi-Moghadam, S., Goodarzi, P., Rezaei–Tavirani, M., Payab, M., Gholami, M., Razi, F., & Arjmand, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_491 · Cited by 15
Stem Cells for Improving the Treatment of Neurodevelopmental Disorders
Donegan, J. J., & Lodge, D. J. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0265 · Cited by 14
“improvements were found on the social relationship and reciprocity, emotional responsiveness, speech, language, and communication, behavior patterns, sensory aspect, and cognitive component subscales [146].”
BackgroundKobinia, G. S., Zaknun, J. J., Pabinger, C., & Laky, B. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.620188 · Cited by 12
Kulkarni, P., Sharma, A. K., Kulkarni, R., Sane, H. M., Awad, N. T., Bopardikar, A., Joshi, A. R., Baveja, S., Joshi, M. A., Vishwanathan, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1279607/v1 · Cited by 12
Self-citationMoral obligations in conducting stem cell-based therapy trials for autism spectrum disorder
Yeo-Teh, N. S. L., & Tang, B. L. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2020-107106 · Cited by 11
Neuro-rehabilitation - a multidisciplinary approach
Deora, H. (2019) · Neurology India · doi:10.4103/0028-3886.253611 · Cited by 10
Darwish, M., Hajj, R. E., Khayat, L., & Alaaeddine, N. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10724-4 · Cited by 9
“…by secreting diverse bioactive molecules, known as the secretome, including various diffusible neurotrophic and growth factors, which could influence the autistic CNS by enhancing neuroprotection, neural circuit reconstruction, neural plasticity, neurogenesis, and immunomodulation [ 100 ].”
InfluentialSharma, A. K., Sane, H. M., Gokulchandran, N., Pai, S., Kulkarni, P., Ganwir, V., Maheshwari, M., Sharma, R., Raichur, M., Nivins, S., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0748-2 · Cited by 9
Self-citationImmune Modulatory Treatments for Autism Spectrum Disorder
Thom, R. P., & McDougle, C. J. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100836 · Cited by 11
Narzisi, A., Halladay, A. K., Masi, G., Novarino, G., & Lord, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1287879 · Cited by 8
Clinical neurorestorative progress in multiple sclerosis
Geng, T., & Mark, V. W. (2015) · Journal of Neurorestoratology · doi:10.2147/jn.s74146 · Cited by 8
“Sharma et al showed that the metabolic function of many parts of the CNS significantly changed after cell treatment in patients with chronic stroke and autism.(46,47)”
Cell therapies for autism spectrum disorder: a systematic review of clinical applications
Akat, A., & Karaöz, E. (2023) · Middle East Current Psychiatry · doi:10.1186/s43045-023-00363-9 · Cited by 8
“For studies that used intrathecal BM-MNC applications, the cell dosage ranged from 2.69 to 42.3 × 10 6 /kg BM-MNCs (in Sharma et al.’s 2013 [78] study, the average age at intervention was reported to be 10.4, and the average weight of a 10-year-old child is 30.4 kg according to WHO, so these…”
BackgroundMethodInfluentialPotential Neuroimaging Biomarkers for Autism Spectrum Disorder
Subtirelu, R. C., Writer, M., Teichner, E. M., Patil, S., Indrakanti, D., Werner, T. J., & Alavi, A. A. (2024) · PET Clinics · doi:10.1016/j.cpet.2024.09.010 · Cited by 7
Liêm, N. T., Nguyen, P. M., Nguyen, H.-P., Bui, H. T., Dao, L. T. M., Pham, M. V., Hoang, C. K., Nguyen, P. T., Nguyễn, T. T. P., Nguyen, A. T. P., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04404-4 · Cited by 9
“Although the safety and efficacy of intrathecal bone marrow mononuclear cell (BMMNC) administration for the treatment of ASD have been reported in various studies [29, 33, 36], to our knowledge, no randomized controlled trial (RCT) has been conducted to verify the effectiveness of this approach.”
Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
Sivanesan, S., Tan, A., Jeyaraj, R., Lam, J. M., Gole, M., Hardan, A. Y., Ashkan, K., & Rajadas, J. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.09.100 · Cited by 8
Simberlund, J., Ferretti, C. J., & Hollander, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1067372 · Cited by 9
“Sharma et al. (2013a) Sharma et al. (2013b) Lv et al. (2013) Study type Case report Phase I/II clinical trail Phase I/II clinical trial Location India India China Number of patients who received treatment 1 32 9 Treatment BMMNC BMMNC CBMNC & UCMSC Route of administration Intrathecal Intrathecal…”
BackgroundMethodInfluentialSharma, A. K. (2014) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000164 · Cited by 6
“Recent advances in the cellular therapy have led to a neurorestorative approach for the treatment of pediatric neurological diseases [1-3] Cellular therapy is being widely explored for the treatment of various incurable neurological disorders [2,4-7].”
BackgroundMethodSelf-citationPET - CT Scan Shows Decreased Severity of Autism after Autologous Cellular Therapy: A Case Report
Sharma, A. K. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000169 · Cited by 6
“Cell therapy has been widely studied and has shown to have potential as a novel treatment for various neurological disorders including autism [5-10].”
BackgroundSelf-citationCytokine Dynamics in Autism: Analysis of BMAC Therapy Outcomes
Maric, D. M., Vojvodić, D., Maric, D. L., Velikic, G. S., Radomir, M., Sokolovac, I., Štefik, D., Ivkovic, N., Šušnjević, S., Puletić, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015080 · Cited by 6
Stem Cell Therapy in Pediatric Neurological Disabilities
Sharma, A., Sane, H. M., Gokulchandran, N., Badhe, P. B., Kulkarni, P., Pai, S., Varghese, R., & Paranjape, A. (2017) · InTech eBooks · doi:10.5772/67656 · Cited by 6
“[58] Autologous bone marrow mononuclear cells (BMMNCs) Intrathecal 32 29 Yes”
BackgroundSelf-citationSharma, A. K., Gokulchandran, N., Sane, H. M., Patil, A., Shetty, A., Biju, H., Kulkarni, P., & Badhe, P. B. (2015) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-3-10-1 · Cited by 4
“Commonly prescribed therapeutics include antipsychotics, serotonin reuptake inhibitors, psychostimulants and mood stabilizers, along with the use of Methylphenidate for treating hyperactivity or attention deficit [9].”
BackgroundInfluentialSelf-citationBui, H. T. P., Do, D. H., Ly, H. T. T., Tran, K. T., Le, H. T. T., Nguyen, K. T., Pham, L. T. D., Le, H. D., Le, V. S., Mukhopadhyay, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290936 · Cited by 4
“Some studies have shown promising results suggesting that stem cell therapy could be an additional treat-ment for autism [19–21], however further research is needed to demonstrate the safety and effectiveness of this approach.”
BackgroundStem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades
Villanueva, R. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492415 · Cited by 7
Sharma, A., Gokulchandran, N., Sane, H. M., Kulkarni, P., Kannan, K., Shaikh, Z., Biju, H., Paranjape, A., D'sa, M., & Badhe, P. B. (2025) · Clinical Transplantation and Research · doi:10.4285/ctr.25.0009 · Cited by 4
“On the CGI-II, 96% of patients demonstrated global improvement; few AEs were observed, including seizures in three patients, and were controlled with medication [17].”
Self-citationMartinez, L. V., MartÍnez-Garza, L. E., Rodriguez-Sanchez, I. P., Álvarez‐Villalobos, N. A., Guzmán-Gallardo, F., Pope-Salazar, S., Salinas-Silva, C., Cepeda-Cepeda, M. G., Garza‐Bedolla, A., Domínguez‐Varela, I. A., et al. (2022) · PubMed · Cited by 7
Liêm, N. T., Nguyen, H.-P., & Hoang, D. M. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.063 · Cited by 4
Knudsen, L. V., Vafaee, M. S., Sheldrick, A. J., & Michel, T. M. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-025-03093-w · Cited by 3
Neuropsychiatric Disorder Tackled by Innovative Cell Therapy-A Case Report in Autism
Sharma, A. K., Kulkarni, P., Sane, H. M., & Badhe, P. B. (2014) · Cited by 3
Self-citationA snapshot on introspection of autism spectrum disorder
Kale, G., Addepalli, V., & Joshi, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09514-5 · Cited by 3
“In theory, cellular therapy aims to address these issues by promoting angiogenesis to enhance perfusion and regulating the immune sys-tem to alleviate inflammation [75].”
Sharma, A. K., Gokulchandran, N., Sane, H. M., Biju, H., Shetty, A., Kali, M., Badhe, P. B., & Bhovad, P. (2015) · Journal of Pediatric Neurology · doi:10.3233/jpn-140656 · Cited by 4
“[3–7].”
Self-citationChavan, C., Ray, S., & Kumar, C. M. (2024) · The Indian Journal of Medical Research · doi:10.25259/ijmr_2141_23 · Cited by 3
Emerging Uses of Cord Blood in Regenerative Medicine—Neurological Applications
Sun, J. M., & Kurtzberg, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407785-0.00013-x · Cited by 2
Sharma, A. K., Sane, H. M., Paranjape, A., Gokulchandran, N., Gandhi, S., & Badhe, P. B. (2016) · Journal of Case Reports · doi:10.17659/01.2016.0020 · Cited by 2
“Human trials of autologous BMMNCs have also reported to be safe with no adverse effects [3,4].”
BackgroundResultSelf-citationA Case of Autism Showing Clinical Improvements after Cellular Therapy along with PET CT Evidence
Kulkarni, P. (2017) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2017.02.00070 · Cited by 3
“Recent studies of cellular therapy in children with autism have shown significant clinical improvements [6-13].”
BackgroundSelf-citationShamim, S., Khan, N., Greene, D. L., Habiba, U. E., & Umer, A. (2023) · Regenerative Medicine · doi:10.2217/rme-2022-0176 · Cited by 2
Aghoghovwia, B. E., Okpe, O., McIntyre, E., Taniyohwo, E. M., & Ratnayake, J. T. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-021-00189-3 · Cited by 2
Usach, V., Casadei, M., Piñero, G., Vence, M., Soto, P. A., Cueto, A., Brumovsky, P. R., & Setton-Avruj, C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312482 · Cited by 1
“BMMCs are capable of stimulating neovascularization [17] or re-epithelialization and wound healing [18], and their therapeutic value has been further studied in several recent clinical trails [19–26].”
Kala, S., Aggarwal, A., Rajput, B. S., Kala, C., & Barman, S. K. (2024) · Cureus · doi:10.7759/cureus.75617 · Cited by 1
Kobinia, G. S., Bukaty, A., Holly, E., Kobinia, G., Heuberer, P. R., & Laky, B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1666486 · Cited by 1
Rethinking on ethics and regulations in cell therapy as part of neurorestoratology
Alok, S., & Zoubi, Z. M. A. (2016) · Journal of Neurorestoratology · doi:10.2147/jn.s74135 · Cited by 1
“Statistically significant improvements were noted on outcome measures like the Clinical Global Impact scale and the Indian Scale for Assessment of Autism, which grade the severity of the disease, and a clinically significant change was also found in functional independence, as measured on the Functional Independence M…”
Sharma, A. K., Sane, H. M., Pradhan, R., Paranjape, A., Gokulchandran, N., Kaur, J., Das, R., & Badhe, P. B. (2019) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v6i2.11 · Cited by 1
Self-citationStem Cell Therapy in Motor Neuron Disease
Sharma, A. K., Sane, H. M., Gokulchandran, N., Badhe, P. B., Paranjape, A., Pradhan, R., Das, R., & Biju, H. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87116 · Cited by 1
Self-citationStem Cell Therapy for Learning Disability
Sharma, A. K., Gokulchandran, N., Sane, H. M., Desai, S. S., Kulkarni, P., & Badhe, P. B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101511 · Cited by 1
Self-citationChiomento, J. L. T., Nardi, F. S. D., Grando, L. A., Trentin, T. D. S., Anzolin, J., Albrecht, G. E., Huzar‐Novakowiski, J., Basílio, L. S. P., Monteiro, G. C., & Lima, G. P. P. (2024) · Bragantia · doi:10.1590/1678-4499.20230219 · Cited by 1
Regenerative Potential of Cord Blood
Sun, J. M., & Kurtzberg, J. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-06444-4_2 · Cited by 1
Diferenciação de células derivadas da medula óssea em células tipo-hepatócitos
Simon, L. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Stem Cell Therapy in Pediatric Neurological Disorders
Torabian, F., Nejad, A. A., Rezayat, A. A., Toosi, M. B., Nakhaie, A. R. A., & Rahimi, H. R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Stem cells for neonatal hypoxic-ischemic injury
Carroll, J. E. (2013) · Cell and Organ Transplantology · doi:10.22494/cot.v1i1.44
Pham, P. V. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-33720-3_7
Using Shank3 Model Mice to Probe the Neuroanatomic Basis of Autism
Bey, A. L. (2017) · DukeSpace (Duke University)
Sharma, A., Sane, H. M., Gokulchandran, N., Kulkarni, P., Jose, A., Ganar, V., Nivins, S., & Badhe, P. B. (2018) · Journal of Neuropsychiatry · doi:10.21767/2471-8548.10010
Self-citationMancías‐Guerra, C., Sánchez-García, S. A., Velasco-Ruiz, I., Huerta-Rangel, R., Carreño-Salcedo, S. A., & González‐Llano, Ó. (2021) · Medicina Universitaria · doi:10.24875/rmu.21000008
Effectiveness of Stem Cell Therapy in Autism Spectrum Disorders: Case Study of Identical Twins
Sandhya, K., & Shobha, H. C. (2021) · Austin Journal of Autism & Related Disabilities · doi:10.26420/austinjautismrelatdisabil.2021.1057
Metadata
- Authors
- Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., Shetty, A., Mishra, P., Kali, M., Biju, H., & Badhe, P.
- Affiliations
- Neurogen Brain & Spine Institute (IN)
- Corresponding author
- Kulkarni, Pooja
- ORCID
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-13
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC3767048
- OpenAlex
- W2105688599
- Cited by
- 110
- References
- 108
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 12 · 2020: 13 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 16 · 2014: 7 · 2013: 2
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, autologous bone marrow mononuclear cells, cell therapy, intrathecal transplantation, cerebral hypoperfusion, angiogenesis, neuroinflammation, immune regulation, functional outcome, adverse events, seizures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.